Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

DSM ComfortCoat® Hydrophilic Coating Utilized in New Drug Eluting Stent Delivery System from CID SpA

November 15, 2011 By AxoGen, Inc.

BERKELEY,
Calif.–(BUSINESS WIRE)–DSM, a
global leader in biomedical materials science, today announced the use of its
ComfortCoat® hydrophilic coating on the delivery system of CID SpAs new Cre8™
Drug Eluting Stent (DES), CE marked the 16th of July 2011.

“As DSMs materials portfolio continues to expand with novel
coating materials, the successful launch of Cre8 DES is another strong
testament to the value we provide medical device manufacturers across the
globe.”

CID SpA chose ComfortCoat® hydrophilic coating, a
proprietary DSM product and technology, since it facilitates the treatment of
more complex patient anatomies by enhancing the deliverability of its
stentdelivery systems during percutaneous coronary intervention procedures.

Recently released data has not only proven the unmatched
effectiveness of Cre8™ DES in patients with coronary artery disease, but
showcases the potential for this type of drug eluting stent system to help
physicians shorten the dual antiplatelet therapy period for their
patients.Further, CID is leveraging the latest advanced delivery system
technologies, particularly the ComfortCoat® hydrophilic coating, in order to
maximize acute device performances.

“The launch of Cre8 DES aligns with our mission of supporting
interventional cardiologists and their patients with the development of
innovative systems that positively impact patient outcomes, in terms of
efficacy and safety, while also helping to reduce costs within the healthcare
delivery system,” said Franco Vallana, president and CEO of CID SpA. “By
collaborating with DSM, we are able to ensure interventional cardiologists
receive the benefits of the worlds most advanced technologies within our drug
eluting stent systems.”

“Our long-standing partnership with CID reaffirms our
continued commitment to providing innovative material solutions for the
cardiovascular market, which, ultimately, help to lower patient risk and
improve procedural outcomes,” said John Marugg, Business Manager Coatings, DSM
Biomedical. “As DSMs materials portfolio continues to expand with novel
coating materials, the successful launch of Cre8 DES is another strong
testament to the value we provide medical device manufacturers across the
globe.”

This announcement precedes the start of COMPAMED, where DSM
will be exhibiting in Hall 8a at booth K28 from November 16-18, 2011 in Düsseldorf, Germany.

DSM – Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in
health, nutrition and materials. By connecting its unique competences in Life
Sciences and Materials Sciences DSM is driving economic prosperity,
environmental progress and social advances to create sustainable value for all
stakeholders. DSM delivers innovative solutions that nourish, protect and
improve performance in global markets such as food and dietary
supplements,personal care, feed, pharmaceuticals, medical devices, automotive,
paints, electrical and electronics, life protection, alternative energy and
bio-based materials. DSMs 22,000 employees deliver annual net sales of about €
9 billion. The company is listed on NYSE Euronext. More information can be
found at www.dsm.com.

CID SpA

CID (Carbostent & Implantable Devices) is dedicated to contributing to
human welfare by improving the quality of patient care and after-care through
the development of innovative, minimally invasive implantable devices,
procedures and therapies. A strong background in the field of implantable
cardiovascular devices and haemocompatible materials, expressed in a remarkable
IP portfolio, and a management with an expertise gained in many years of
research, development and clinical experience, allow CID to offer the investors
a fair return and its customers the necessary tools to meet new challenges.

ComfortCoat® is a registered trademark of Royal DSM N.V.

Cre8™ is a trademark of CID SpA. 

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech